Molecular cancer

Keyphrases

Publications

volume 22, number 1, 2023

Charlotte Smith, Aurore Touzart, Mathieu Simonin, Christine Tran-Quang, Guillaume Hypolite, Mehdi Latiri, Guillaume P Andrieu, Estelle Balducci, Marie-Émilie Dourthe, Ashish Goyal, Françoise Huguet, Arnaud Petit, Norbert Ifrah, André Baruchel, Hervé Dombret, Elizabeth Macintyre, Christoph Plass, Jacques Ghysdael, Nicolas Boissel, Vahid Asnafi
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL. Molecular cancer 22 (1) (2023)
Shuo Ma, Meiling Zhou, Yanhua Xu, Xinliang Gu, Mingyuan Zou, Gulinaizhaer Abudushalamu, Yuming Yao, Xiaobo Fan, Guoqiu Wu
Clinical application and detection techniques of liquid biopsy in gastric cancer. Molecular cancer 22 (1) (2023)
Fei Xing, Hongli Gao, Guanglei Chen, Lisha Sun, Jiayi Sun, Xinbo Qiao, Jinqi Xue, Caigang Liu
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer. Molecular cancer 22 (1) (2023)
Yanping Liang, Junjie Cen, Yong Huang, Yong Fang, Yunfei Wang, Guannan Shu, Yihui Pan, Kangbo Huang, Jiaqi Dong, Mi Zhou, Yi Xu, Junhang Luo, Min Liu, Jiaxing Zhang
Correction: CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug. Molecular cancer 22 (1) (2023)
Zhuohao Liu, Jiayi Zhou, Xinzhi Yang, Yuchen Liu, Chang Zou, Wen Lv, Cheng Chen, Kenneth King-Yip Cheng, Tao Chen, Lung-Ji Chang, Dinglan Wu, Jie Mao
Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma. Molecular cancer 22 (1) (2023)
Dawei Rong, Chen Lu, Betty Zhang, Kai Fu, Shuli Zhao, Weiwei Tang, Hongyong Cao
Retraction Note: CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p. Molecular cancer 22 (1) (2023)
Leli Zeng, B H Jaswanth Gowda, Mohammed Gulzar Ahmed, Mohammed A S Abourehab, Zhe-Sheng Chen, Changhua Zhang, Jia Li, Prashant Kesharwani
Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Molecular cancer 22 (1) (2023)
Chaohui Gu, Zhiyu Wang, Naichun Zhou, Guanru Li, Yiping Kou, Yang Luo, Yidi Wang, Jinjian Yang, Fengyan Tian
Correction: Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6 - methyladenosine of Notch1. Molecular cancer 22 (1) (2023)
Yulan Mo, Leanne L Leung, Celia S L Mak, Xueyu Wang, Wai-Sun Chan, Lynn M N Hui, Hermit W M Tang, Michelle K Y Siu, Rakesh Sharma, Dakang Xu, Stephen K W Tsui, Hextan Y S Ngan, Mingo M H Yung, Karen K L Chan, David W Chan
Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. Molecular cancer 22 (1) (2023)
Zhuohao Liu, Jiayi Zhou, Xinzhi Yang, Yuchen Liu, Chang Zou, Wen Lv, Cheng Chen, Kenneth King-Yip Cheng, Tao Chen, Lung-Ji Chang, Dinglan Wu, Jie Mao
Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma. Molecular cancer 22 (1) (2023)
Keisuke Okuno, Raju Kandimalla, Marta Mendiola, Francesc Balaguer, Luis Bujanda, Carlos Fernandez-Martos, Jorge Aparicio, Jaime Feliu, Masanori Tokunaga, Yusuke Kinugasa, Joan Maurel, Ajay Goel
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer. Molecular cancer 22 (1) (2023)
Katsuki Miyazaki, Yuma Wada, Keisuke Okuno, Tatsuro Murano, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hiroaki Ikematsu, Yusuke Kinugasa, Mitsuo Shimada, Ajay Goel
An exosome-based liquid biopsy signature for pre-operative identification of lymph node metastasis in patients with pathological high-risk T1 colorectal cancer. Molecular cancer 22 (1) (2023)
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura J van 't Veer, Mark Jesus M Magbanua
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance. Molecular cancer 22 (1) (2023)
Charlotte Smith, Aurore Touzart, Mathieu Simonin, Christine Tran-Quang, Guillaume Hypolite, Mehdi Latiri, Guillaume P Andrieu, Estelle Balducci, Marie-Émilie Dourthe, Ashish Goyal, Françoise Huguet, Arnaud Petit, Norbert Ifrah, André Baruchel, Hervé Dombret, Elizabeth Macintyre, Christoph Plass, Jacques Ghysdael, Nicolas Boissel, Vahid Asnafi
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL. Molecular cancer 22 (1) (2023)
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura J van 't Veer, Mark Jesus M Magbanua
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance. Molecular cancer 22 (1) (2023)
Chaohui Gu, Zhiyu Wang, Naichun Zhou, Guanru Li, Yiping Kou, Yang Luo, Yidi Wang, Jinjian Yang, Fengyan Tian
Correction: Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6 - methyladenosine of Notch1. Molecular cancer 22 (1) (2023)
Zhe Liu, Neha Parveen, Urushi Rehman, Aisha Aziz, Afsana Sheikh, Mohammed A S Abourehab, Wei Guo, Junhao Huang, Zhenning Wang, Prashant Kesharwani
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Molecular cancer 22 (1) (2023)
Yu Tian, Haijuan Xiao, Yanhui Yang, Pingping Zhang, Jiahui Yuan, Wei Zhang, Lijie Chen, Yibao Fan, Jinze Zhang, Huan Cheng, Tingwei Deng, Lin Yang, Weiwei Wang, Guoyong Chen, Peiqin Wang, Peng Gong, Xing Niu, Xianbin Zhang
Crosstalk between 5-methylcytosine and N 6 -methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma. Molecular cancer 22 (1) (2023)
Dawei Rong, Chen Lu, Betty Zhang, Kai Fu, Shuli Zhao, Weiwei Tang, Hongyong Cao
Retraction Note: CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p. Molecular cancer 22 (1) (2023)
Fei Xing, Hongli Gao, Guanglei Chen, Lisha Sun, Jiayi Sun, Xinbo Qiao, Jinqi Xue, Caigang Liu
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer. Molecular cancer 22 (1) (2023)
Zhuohao Liu, Jiayi Zhou, Xinzhi Yang, Yuchen Liu, Chang Zou, Wen Lv, Cheng Chen, Kenneth King-Yip Cheng, Tao Chen, Lung-Ji Chang, Dinglan Wu, Jie Mao
Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma. Molecular cancer 22 (1) (2023)
Yulan Mo, Leanne L Leung, Celia S L Mak, Xueyu Wang, Wai-Sun Chan, Lynn M N Hui, Hermit W M Tang, Michelle K Y Siu, Rakesh Sharma, Dakang Xu, Stephen K W Tsui, Hextan Y S Ngan, Mingo M H Yung, Karen K L Chan, David W Chan
Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. Molecular cancer 22 (1) (2023)
Fei Xing, Hongli Gao, Guanglei Chen, Lisha Sun, Jiayi Sun, Xinbo Qiao, Jinqi Xue, Caigang Liu
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer. Molecular cancer 22 (1) (2023)
Katsuki Miyazaki, Yuma Wada, Keisuke Okuno, Tatsuro Murano, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hiroaki Ikematsu, Yusuke Kinugasa, Mitsuo Shimada, Ajay Goel
An exosome-based liquid biopsy signature for pre-operative identification of lymph node metastasis in patients with pathological high-risk T1 colorectal cancer. Molecular cancer 22 (1) (2023)
Zhuohao Liu, Jiayi Zhou, Xinzhi Yang, Yuchen Liu, Chang Zou, Wen Lv, Cheng Chen, Kenneth King-Yip Cheng, Tao Chen, Lung-Ji Chang, Dinglan Wu, Jie Mao
Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma. Molecular cancer 22 (1) (2023)
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura J van 't Veer, Mark Jesus M Magbanua
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance. Molecular cancer 22 (1) (2023)
Parvez Khan, Jawed Akhtar Siddiqui, Prakash G Kshirsagar, Ramakanth Chirravuri Venkata, Shailendra Kumar Maurya, Tamara Mirzapoiazova, Naveenkumar Perumal, Sanjib Chaudhary, Ranjana Kumari Kanchan, Mahek Fatima, Md Arafat Khan, Asad Ur Rehman, Imayavaramban Lakshmanan, Sidharth Mahapatra, Geoffrey A Talmon, Prakash Kulkarni, Apar K Ganti, Maneesh Jain, Ravi Salgia, Surinder Kumar Batra, Mohd Wasim Nasser
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis. Molecular cancer 22 (1) (2023)
Johannes Robert Fleischer, Alexandra Maria Schmitt, Gwendolyn Haas, Xingbo Xu, Elisabeth Maria Zeisberg, Hanibal Bohnenberger, Stefan Küffer, Laure-Anne Teuwen, Philipp Johannes Karras, Tim Beißbarth, Annalen Bleckmann, Mélanie Planque, Sarah-Maria Fendt, Peter Vermeulen, Michael Ghadimi, Joanna Kalucka, Tiago De Oliveira, Lena-Christin Conradi
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Molecular cancer 22 (1) (2023)
Keisuke Okuno, Raju Kandimalla, Marta Mendiola, Francesc Balaguer, Luis Bujanda, Carlos Fernandez-Martos, Jorge Aparicio, Jaime Feliu, Masanori Tokunaga, Yusuke Kinugasa, Joan Maurel, Ajay Goel
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer. Molecular cancer 22 (1) (2023)
Runjie Song, Shuoqian Ma, Jiajia Xu, Xin Ren, Peilan Guo, Huijiao Liu, Peng Li, Fan Yin, Mei Liu, Qiang Wang, Lei Yu, Jiali Liu, Binwei Duan, Nafis A Rahman, Sławomir Wołczyński, Guangming Li, Xiangdong Li
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR. Molecular cancer 22 (1) (2023)
Keisuke Okuno, Raju Kandimalla, Marta Mendiola, Francesc Balaguer, Luis Bujanda, Carlos Fernandez-Martos, Jorge Aparicio, Jaime Feliu, Masanori Tokunaga, Yusuke Kinugasa, Joan Maurel, Ajay Goel
A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer. Molecular cancer 22 (1) (2023)
Yanping Liang, Junjie Cen, Yong Huang, Yong Fang, Yunfei Wang, Guannan Shu, Yihui Pan, Kangbo Huang, Jiaqi Dong, Mi Zhou, Yi Xu, Junhang Luo, Min Liu, Jiaxing Zhang
Correction: CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug. Molecular cancer 22 (1) (2023)
Charlotte Smith, Aurore Touzart, Mathieu Simonin, Christine Tran-Quang, Guillaume Hypolite, Mehdi Latiri, Guillaume P Andrieu, Estelle Balducci, Marie-Émilie Dourthe, Ashish Goyal, Françoise Huguet, Arnaud Petit, Norbert Ifrah, André Baruchel, Hervé Dombret, Elizabeth Macintyre, Christoph Plass, Jacques Ghysdael, Nicolas Boissel, Vahid Asnafi
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL. Molecular cancer 22 (1) (2023)
Johannes Robert Fleischer, Alexandra Maria Schmitt, Gwendolyn Haas, Xingbo Xu, Elisabeth Maria Zeisberg, Hanibal Bohnenberger, Stefan Küffer, Laure-Anne Teuwen, Philipp Johannes Karras, Tim Beißbarth, Annalen Bleckmann, Mélanie Planque, Sarah-Maria Fendt, Peter Vermeulen, Michael Ghadimi, Joanna Kalucka, Tiago De Oliveira, Lena-Christin Conradi
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Molecular cancer 22 (1) (2023)
Leli Zeng, B H Jaswanth Gowda, Mohammed Gulzar Ahmed, Mohammed A S Abourehab, Zhe-Sheng Chen, Changhua Zhang, Jia Li, Prashant Kesharwani
Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Molecular cancer 22 (1) (2023)
Zhe Liu, Neha Parveen, Urushi Rehman, Aisha Aziz, Afsana Sheikh, Mohammed A S Abourehab, Wei Guo, Junhao Huang, Zhenning Wang, Prashant Kesharwani
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Molecular cancer 22 (1) (2023)
Fei Xing, Hongli Gao, Guanglei Chen, Lisha Sun, Jiayi Sun, Xinbo Qiao, Jinqi Xue, Caigang Liu
CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer. Molecular cancer 22 (1) (2023)
Leli Zeng, B H Jaswanth Gowda, Mohammed Gulzar Ahmed, Mohammed A S Abourehab, Zhe-Sheng Chen, Changhua Zhang, Jia Li, Prashant Kesharwani
Advancements in nanoparticle-based treatment approaches for skin cancer therapy. Molecular cancer 22 (1) (2023)
Shuo Ma, Meiling Zhou, Yanhua Xu, Xinliang Gu, Mingyuan Zou, Gulinaizhaer Abudushalamu, Yuming Yao, Xiaobo Fan, Guoqiu Wu
Clinical application and detection techniques of liquid biopsy in gastric cancer. Molecular cancer 22 (1) (2023)
Zhe Liu, Neha Parveen, Urushi Rehman, Aisha Aziz, Afsana Sheikh, Mohammed A S Abourehab, Wei Guo, Junhao Huang, Zhenning Wang, Prashant Kesharwani
Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Molecular cancer 22 (1) (2023)
Yulan Mo, Leanne L Leung, Celia S L Mak, Xueyu Wang, Wai-Sun Chan, Lynn M N Hui, Hermit W M Tang, Michelle K Y Siu, Rakesh Sharma, Dakang Xu, Stephen K W Tsui, Hextan Y S Ngan, Mingo M H Yung, Karen K L Chan, David W Chan
Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. Molecular cancer 22 (1) (2023)
Runjie Song, Shuoqian Ma, Jiajia Xu, Xin Ren, Peilan Guo, Huijiao Liu, Peng Li, Fan Yin, Mei Liu, Qiang Wang, Lei Yu, Jiali Liu, Binwei Duan, Nafis A Rahman, Sławomir Wołczyński, Guangming Li, Xiangdong Li
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR. Molecular cancer 22 (1) (2023)
Yu Tian, Haijuan Xiao, Yanhui Yang, Pingping Zhang, Jiahui Yuan, Wei Zhang, Lijie Chen, Yibao Fan, Jinze Zhang, Huan Cheng, Tingwei Deng, Lin Yang, Weiwei Wang, Guoyong Chen, Peiqin Wang, Peng Gong, Xing Niu, Xianbin Zhang
Crosstalk between 5-methylcytosine and N 6 -methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma. Molecular cancer 22 (1) (2023)
Shuo Ma, Meiling Zhou, Yanhua Xu, Xinliang Gu, Mingyuan Zou, Gulinaizhaer Abudushalamu, Yuming Yao, Xiaobo Fan, Guoqiu Wu
Clinical application and detection techniques of liquid biopsy in gastric cancer. Molecular cancer 22 (1) (2023)
Runjie Song, Shuoqian Ma, Jiajia Xu, Xin Ren, Peilan Guo, Huijiao Liu, Peng Li, Fan Yin, Mei Liu, Qiang Wang, Lei Yu, Jiali Liu, Binwei Duan, Nafis A Rahman, Sławomir Wołczyński, Guangming Li, Xiangdong Li
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR. Molecular cancer 22 (1) (2023)
Marcia Bellon, Christophe Nicot
Targeting Pim kinases in hematological cancers: molecular and clinical review. Molecular cancer 22 (1) (2023)
Yu Tian, Haijuan Xiao, Yanhui Yang, Pingping Zhang, Jiahui Yuan, Wei Zhang, Lijie Chen, Yibao Fan, Jinze Zhang, Huan Cheng, Tingwei Deng, Lin Yang, Weiwei Wang, Guoyong Chen, Peiqin Wang, Peng Gong, Xing Niu, Xianbin Zhang
Crosstalk between 5-methylcytosine and N 6 -methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma. Molecular cancer 22 (1) (2023)
Katsuki Miyazaki, Yuma Wada, Keisuke Okuno, Tatsuro Murano, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hiroaki Ikematsu, Yusuke Kinugasa, Mitsuo Shimada, Ajay Goel
An exosome-based liquid biopsy signature for pre-operative identification of lymph node metastasis in patients with pathological high-risk T1 colorectal cancer. Molecular cancer 22 (1) (2023)
Parvez Khan, Jawed Akhtar Siddiqui, Prakash G Kshirsagar, Ramakanth Chirravuri Venkata, Shailendra Kumar Maurya, Tamara Mirzapoiazova, Naveenkumar Perumal, Sanjib Chaudhary, Ranjana Kumari Kanchan, Mahek Fatima, Md Arafat Khan, Asad Ur Rehman, Imayavaramban Lakshmanan, Sidharth Mahapatra, Geoffrey A Talmon, Prakash Kulkarni, Apar K Ganti, Maneesh Jain, Ravi Salgia, Surinder Kumar Batra, Mohd Wasim Nasser
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis. Molecular cancer 22 (1) (2023)
Parvez Khan, Jawed Akhtar Siddiqui, Prakash G Kshirsagar, Ramakanth Chirravuri Venkata, Shailendra Kumar Maurya, Tamara Mirzapoiazova, Naveenkumar Perumal, Sanjib Chaudhary, Ranjana Kumari Kanchan, Mahek Fatima, Md Arafat Khan, Asad Ur Rehman, Imayavaramban Lakshmanan, Sidharth Mahapatra, Geoffrey A Talmon, Prakash Kulkarni, Apar K Ganti, Maneesh Jain, Ravi Salgia, Surinder Kumar Batra, Mohd Wasim Nasser
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis. Molecular cancer 22 (1) (2023)